Jerry Gin

Manager,                                                     Jerry Gin - Manager


Jerry has spent 40 years in the health care/pharmaceutical/diagnostic/biotechnology areas.  In 2006, Jerry co-founded Nuvora, the company whose motto is “the ultimate oral care company”.  Since that time, the company has developed four products which are now on the market.  As President and CEO, he is developing Nuvora to be the leading drug delivery company for oral care.

Jerry co-founded Oculex Pharmaceuticals in 1993 and oversaw its successful start-up which eventually led to the acquisition by Allergan. As President and CEO, he developed the technology for controlled release delivery of drugs to the interior of the eye, specifically to treat macular edema.  Subsequent to Oculex, Jerry became  Chairman of Chakshu Research, an ophthalmic company developing an eye drop that improves vision for persons with cataracts.

Prior to forming Oculex, Jerry co-founded his first company, ChemTrak, developers of the home cholesterol test commonly available in drug stores today. Jerry successfully took the company public and ventured on to form Oculex.

Prior to ChemTrak, Jerry was the Director of New Business Development and Strategic Planning for Syva, the diagnostic arm of Syntex Pharmaceuticals. Prior to Syntex, Jerry directed the international pharmaceutical and diagnostic businesses for Dow Chemical. In addition, he initiated and was Director of a number of Dow’s reference laboratories that were eventually sold to SmithKline Beecham and are currently known as Quest Laboratories.

Jerry has conducted research at the National Institutes of Health and is certified by the American Association for Clinical Chemistry and the American Society of Clinical Pathologists. He has also contributed to various publications in clinical chemistry and biochemistry. As is his paradigm, Jerry has put his expertise into practice by inventing--filing approximately 15 patents in areas ranging from drug delivery to systems for treating or diagnosing ophthalmic, dental, orthopedic or cardiovascular problems.

Dr. Gin received his B.S. in Chemistry from the University of Arizona, his Ph.D. in Biochemistry from the University of California, Berkeley, and his M.B.A. from Loyola College.